Live from the NIH registry
Studies recruiting near Portland right now
Top 25 of 165 recruiting studies, sorted by proximity — each links to its official registry page
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
MaineHealth Maine Medical Center- Scarborough — Scarborough, Maine (7.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Maine Children's Cancer Program — Scarborough, Maine (7.3 mi)
· Sponsor: National Cancer Institute (NCI)
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 614 participants sought
New England Cancer Specialists ( Site 0143) — Westbrook, Maine (5.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
MaineHealth Pediatric Specialty Care — Portland, Maine (1.5 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 75 participants sought
Maine Medical Center — Scarborough, Maine (7.3 mi)
· Sponsor: Turning Point Therapeutics, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: NRG Oncology
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
New England Cancer Specialists — Scarborough, Maine (7.3 mi)
· Sponsor: Jazz Pharmaceuticals
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Maine Eye Center - Marginal Way Campus /ID# 275039 — Portland, Maine (1.5 mi)
· Sponsor: AbbVie
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Maine Children's Cancer Program — Scarborough, Maine (7.3 mi)
· Sponsor: National Cancer Institute (NCI)
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
Community-acquired Pneumonia
Phase 3
Interventional 4,000 participants sought
Maine Medical Centre — Portland, Maine (1.5 mi)
· Sponsor: University of Manitoba
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
MaineHealth Maine Medical Center- Scarborough — Scarborough, Maine (7.3 mi)
· Sponsor: National Cancer Institute (NCI)
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Scarborough, Maine (7.3 mi)
· Sponsor: Massive Bio, Inc.
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
MaineMed Vascular Surgery — Scarborough, Maine (7.3 mi)
· Sponsor: Nectero Medical, Inc.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Maine Medical Center Bramhall — Portland, Maine (1.5 mi)
· Sponsor: Novo Nordisk A/S
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 400 participants sought
Research Site — South Portland, Maine (2.9 mi)
· Sponsor: AstraZeneca
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Maine Children's Cancer Program — Scarborough, Maine (7.3 mi)
· Sponsor: PedAL BCU, LLC
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
N/A
Interventional 600 participants sought
Maine Medical Center — Portland, Maine (1.5 mi)
· Sponsor: Medtronic Cardiovascular
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 3
Interventional 1,160 participants sought
Research Site — Scarborough, Maine (7.3 mi)
· Sponsor: AstraZeneca
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 93 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
MaineHealth Cancer Care -South Portland — South Portland, Maine (2.9 mi)
· Sponsor: American Society of Clinical Oncology
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: NRG Oncology
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia
Phase 2
Interventional 153 participants sought
MaineHealth Maine Medical Center - Portland — Portland, Maine (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Delirium, Neurocognitive Disorders
N/A
Interventional 1,900 participants sought
MaineHealth — Portland, Maine (1.5 mi)
· Sponsor: University of Michigan